MedTrace Logo

Study of the Long-term Effects of Exercise on Heath Indicators in Older People

NCT01874132 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2017-05-08

Study results available
· View outcomes & findings →

Summary

Cardiovascular diseases (CVD) represent the most frequent cause of death among the elderly population. Hypertension, unfavorable lipid profile, obesity and physical inactivity are among the main risk factors for CVD. In contrast, mortality from CVD is inversely related to levels of physical activity, and is lower in individuals who exercise and have higher functional fitness levels. Thus, the Centers for Disease Control and Prevention, the American College of Sports Medicine, and the American Heart Association have recommended 20-30 min of moderate-to-vigorous aerobic training for the elderly, preferably every day or at least 3 days a week in the case of vigorous exercise.The same organizations also suggest the inclusion of resistance training in order to improve functional fitness. Therefore, the purpose of this study was to compare different exercise modalities in long-term changes of CVD risk factors and physical fitness among older adults.

Conditions

  • Hypertension With Complications and Secondary Hypertension
  • Overweight and Obesity
  • Lipid Metabolism Disorders
  • Sarcopenia
  • Osteoporosis
  • Personal Satisfaction

Interventions

BEHAVIORAL

Exercise training

Both training programs were of moderate-to-vigorous intensity, three days per week for nine months.

Sponsors & Collaborators

  • University of Trás-os-Montes and Alto Douro

    lead OTHER

Principal Investigators

  • Nelson Sousa, PhD · Research Center in Sport Sciences, Health Sciences and Human Development; University of Trás-os-Montes e Alto Douro

  • José Oliveira, PhD · Research Center in Physical Activity, Health and Leisure; Sport Faculty, University of Porto

  • Romeu Mendes, MD · University of Trás-os-Montes and Alto Douro

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Max Age
79 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2011-09-30
Completion
2014-09-30

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01874132 on ClinicalTrials.gov